Hypoxia increases persulfide and polysulfide formation by AMP kinase dependent cystathionine gamma lyase phosphorylation.

AMP kinase Cystathionine gamma lyase Ischemia Molecular modeling Persulfide Phosphorylation Polysulfide

Journal

Redox biology
ISSN: 2213-2317
Titre abrégé: Redox Biol
Pays: Netherlands
ID NLM: 101605639

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 30 09 2023
revised: 26 10 2023
accepted: 27 10 2023
medline: 6 12 2023
pubmed: 6 11 2023
entrez: 3 11 2023
Statut: ppublish

Résumé

Hydropersulfide and hydropolysulfide metabolites are increasingly important reactive sulfur species (RSS) regulating numerous cellular redox dependent functions. Intracellular production of these species is known to occur through RSS interactions or through translational mechanisms involving cysteinyl t-RNA synthetases. However, regulation of these species under cell stress conditions, such as hypoxia, that are known to modulate RSS remain poorly understood. Here we define an important mechanism of increased persulfide and polysulfide production involving cystathionine gamma lyase (CSE) phosphorylation at serine 346 and threonine 355 in a substrate specific manner, under acute hypoxic conditions. Hypoxic phosphorylation of CSE occurs in an AMP kinase dependent manner increasing enzyme activity involving unique inter- and intramolecular interactions within the tetramer. Importantly, both cellular hypoxia and tissue ischemia result in AMP Kinase dependent CSE phosphorylation that regulates blood flow in ischemic tissues. Our findings reveal hypoxia molecular signaling pathways regulating CSE dependent persulfide and polysulfide production impacting tissue and cellular response to stress.

Identifiants

pubmed: 37922764
pii: S2213-2317(23)00350-6
doi: 10.1016/j.redox.2023.102949
pmc: PMC10641705
pii:
doi:

Substances chimiques

persulfides 0
polysulfide 9080-49-3
Hydrogen Sulfide YY9FVM7NSN
Adenylate Kinase EC 2.7.4.3
Cystathionine gamma-Lyase EC 4.4.1.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102949

Subventions

Organisme : NHLBI NIH HHS
ID : R00 HL122354
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM121307
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL098435
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL133497
Pays : United States
Organisme : NHLBI NIH HHS
ID : K99 HL122354
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL149264
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL145753
Pays : United States

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest C.G.K., G.K·K., S.A., and X.S. have a provisional patent on CSE phosphorylation mutants and uses.

Auteurs

Shafiul Alam (S)

Department of Pathology, LSU Health Sciences Center, Shreveport, USA.

Sibile Pardue (S)

Department of Pathology, LSU Health Sciences Center, Shreveport, USA.

Xinggui Shen (X)

Department of Pathology, LSU Health Sciences Center, Shreveport, USA.

John D Glawe (JD)

Department of Pathology, LSU Health Sciences Center, Shreveport, USA.

Takashi Yagi (T)

Department of Pathology, LSU Health Sciences Center, Shreveport, USA.

Mohammad Alfrad Nobel Bhuiyan (MAN)

Internal Medicine, LSU Health Sciences Center, Shreveport, USA.

Rakesh P Patel (RP)

Department of Pathology, University of Alabama at Birmingham, USA.

Paari S Dominic (PS)

Internal Medicine-Cardiovascular Medicine, University of Iowa Healthcare, Iowa, USA.

Chiranjiv S Virk (CS)

Department of Surgery, LSU Health Sciences Center, Shreveport, USA.

Md Shenuarin Bhuiyan (MS)

Department of Pathology, LSU Health Sciences Center, Shreveport, USA.

A Wayne Orr (AW)

Department of Pathology, LSU Health Sciences Center, Shreveport, USA.

Chad Petit (C)

Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, USA.

Gopi K Kolluru (GK)

Department of Pathology, LSU Health Sciences Center, Shreveport, USA.

Christopher G Kevil (CG)

Department of Pathology, LSU Health Sciences Center, Shreveport, USA; Department of Cellular Biology and Anatomy, LSU Health Sciences Center, Shreveport, USA; Department of Molecular and Cellular Physiology, LSU Health Sciences Center, Shreveport, USA. Electronic address: chris.kevil@lsuhs.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH